Search
for
Sort by
Research 30 of 526
- Development of Alopecia Areata Universalis in a Patient Receiving Adalimumab
- Alopecia Areata following Adalimumab
- Alopecia Universalis Successfully Treated With Adalimumab
- Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Repigmentation of hair following adalimumab therapy
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- A case of recalcitrant pediatric Vogt-Koyanagi-Harada disease successfully controlled with adalimumab
- Adalimumab-related alopecia in a patient affected by psoriasis
- Adalimumab‐induced scalp psoriasis with severe alopecia
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease
- Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features
- Alopecia universalis unter Adalimumabtherapie bei einer Patientin mit rheumatoider Arthritis
- Folliculitis decalvans managed with adalimumab: A case report
- Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab
- Adalimumab improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): Results from the first 12 weeks of PIONEER II
- Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study
- Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
- AB0326 REAL-WORLD EXPERIENCE ON SWITCHING ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN INFLAMMATORY ARTHRITIS – A RETROSPECTIVE STUDY
- Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa
- Successful Treatment of Adalimumab-Induced Paradoxical Skin Reactions in Pustulotic Arthro-Osteitis With Guselkumab
- Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
- Alopecia Universalis: an extremely rare but probable adverse effect of adalimumab
- THU0239 Methotrexate Dose has Minimal Effects on Methotrexate-Related Toxicity in Patients with Early Rheumatoid Arthritis Treated in Combination with Adalimumab – Results of Concerto Trial
- Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients